Back to search

Article

Associations of Alzheimer’s disease with inpatient hospital costs and with quality-adjusted life years: Evidence from conventional and Mendelian randomization analyses in the UK Biobank

2023-12-10

Abstract excerpt

<h4>ABSTRACT</h4> <h4>BACKGROUND</h4> Alzheimer’s disease and other dementias are progressive neurodegenerative disorders with profound impacts on cognitive function. There is a shortage of economic evidence relating to the impact Alzheimer’s disease on healthcare costs and quality-adjusted life-years (QALYs). <h4>METHODS</h4> We employed two study designs to model the association between Alzheimer’s disease and h...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
e358c129-a327-58af-ae60-e7421e1e44ab
DOI
10.1101/2023.12.09.23299763
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Associations of Alzheimer’s disease with inpatient hospital costs and with quality-adjusted life years: Evidence from conventional and Mendelian randomization analyses in the UK BiobankDOI 10.1101/2023.12.09.23299763
The risk of Alzheimer's disease and cognitive impairment characteristics in eight mental disorders: A UK Biobank observational study and Mendelian randomization analysisSemantic proximity
Estimating the causal effect of genetic liability to prevalent disease on hospital costs using Mendelian RandomizationSemantic proximity
Evidence of a Causal Association Between Cancer and Alzheimer’s Disease: a Mendelian Randomization AnalysisSemantic proximity
Potential cost-effectiveness of individualized medicine in prodromal Alzheimer’s disease by demographic, clinical and cerebrospinal fluid proteomics factorsSemantic proximity
Quantifying the contribution of genetic variation to healthcare expenditure across diverse healthcare systemsSemantic proximity
Using Mendelian Randomization to model the causal effect of cancer on health economic outcomes and to simulate the cost-effectiveness of anti-cancer interventionsSemantic proximity
Low-cost predictive models of dementia risk using machine learning and exposome predictorsSemantic proximity
Lower Incidence of Dementia Following Cancer Diagnoses: Evidence from a Large Cohort and Mendelian Randomization StudySemantic proximity
Quantifying the causal impact of biological risk factors on healthcare costsSemantic proximity
Evaluating the efficacy and mechanism of metformin targets on reducing Alzheimer’s disease risk in the general population: a Mendelian randomisation studySemantic proximity
Estimating the causal effect of liability to disease on healthcare costs using Mendelian Randomization.Semantic proximity
The relationship between glycaemia, cognitive function, structural brain outcomes and dementia: A Mendelian randomization study in the UK BiobankSemantic proximity
Select a neighboring publication to make it the new centre.